Comazzi S, Gelain M E, Riondato F, Paltrinieri S
Department of Veterinary Pathology, Hygiene and Health, University of Milan, via Celoria 10, Milan 20133, Italy.
Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):243-52. doi: 10.1016/j.vetimm.2006.03.004. Epub 2006 May 15.
Flow cytometry is useful to study lymphoid malignancies since it allows both immunophenotyping of neoplastic cells and quantification of antigen expression. CD18 and CD45 are commonly exposed membrane antigens with different levels of expression on blood leukocyte and neoplastic cells. The aim of this retrospective study was to semi-quantitatively evaluate the expression of CD18 and CD45 in dogs with different lymphoid malignancies with blood involvement and to compare results with those from healthy dogs and dogs with reactive diseases. Blood samples from 13 dogs with precursor lymphoid malignancies, 20 with mature neoplasms (either chronic lymphocytic leukaemia or lymphoma), of different immunophenotypes, were compared with 24 healthy dogs and 12 dogs with different reactive diseases. The median fluorescence intensity (MFI) for CD18 and CD45 was recorded on lymphoid and granulocytic populations using dual colour flow cytometry, and the ratio between MFI for lymphoid and granulocytic populations (L/N ratio) was calculated to compare the results obtained in different sessions using an internal control (granulocyte fluorescence intensity). Significant decreases in the L/N ratio were detected in neoplastic samples for both CD18 (either precursors or mature versus controls) and CD45 (either precursors or mature versus control), while using MFI only slight differences were detectable in CD45 between precursors and controls. Neoplastic cells often exhibited lower expression of the L/N ratio for CD18, and mainly for CD45, most likely due to a less mature pattern than normal cells and/or to an aberrant quantitative expression of surface antigen. Moreover, more than 50% of neoplastic lymphoid cells exhibited L/N ratios that were not within the values observed in controls for at least one antigen. Altered L/N ratios, in particular decreases of CD45, were mainly observed in precursor neoplasms and in T-cell neoplasms. Detection of altered expression of common antigens, and in particular a L/N ratio for CD45 lower than a value of 103% may be useful as a confirmation of pseudo-clonality thus helping in differentiating reactive and neoplastic lymphocyte expansions.
流式细胞术对于研究淋巴系统恶性肿瘤很有用,因为它既能对肿瘤细胞进行免疫表型分析,又能对抗原表达进行定量。CD18和CD45是常见的暴露于细胞膜的抗原,在血液白细胞和肿瘤细胞上有不同程度的表达。这项回顾性研究的目的是半定量评估患有不同淋巴系统恶性肿瘤且有血液受累的犬只中CD18和CD45的表达,并将结果与健康犬只和患有反应性疾病的犬只的结果进行比较。将13只患有前体淋巴系统恶性肿瘤、20只患有不同免疫表型的成熟肿瘤(慢性淋巴细胞白血病或淋巴瘤)的犬只的血液样本,与24只健康犬只和12只患有不同反应性疾病的犬只的样本进行比较。使用双色流式细胞术记录淋巴样和粒细胞群体上CD18和CD45的中位荧光强度(MFI),并计算淋巴样和粒细胞群体的MFI之比(L/N比),以使用内部对照(粒细胞荧光强度)比较在不同实验中获得的结果。在肿瘤样本中,CD18(前体或成熟肿瘤与对照相比)和CD45(前体或成熟肿瘤与对照相比)的L/N比均显著降低,而仅使用MFI时,前体与对照之间在CD45上仅可检测到轻微差异。肿瘤细胞通常表现出CD18的L/N比更低,主要是CD45的L/N比更低,这很可能是由于其模式不如正常细胞成熟和/或表面抗原的异常定量表达。此外,超过50%的肿瘤淋巴样细胞表现出至少一种抗原的L/N比不在对照中观察到的值范围内。L/N比的改变,特别是CD45的降低,主要在前体肿瘤和T细胞肿瘤中观察到。检测常见抗原表达的改变,特别是CD45的L/N比低于103%的值,可能有助于确认假克隆性,从而有助于区分反应性和肿瘤性淋巴细胞增殖。